New England Compounding Center, the Massachusetts-based pharmaceutical company that was the source of a deadly fungal meningitis outbreak earlier this year, has filed for Chapter 11 bankruptcy last week. Sources also indicate that the company intends to establish a victims’ compensation fund. In October of 2012, there were reports across several states of cases of […]